• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Acadia Pharmaceuticals Set to Join S&P SmallCap 600

    12/30/24 5:37:00 PM ET
    $ACAD
    $IBTX
    $SPGI
    $SSB
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Major Banks
    Finance
    Get the next $ACAD alert in real time by email

    NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState Corp. (NYSE:SSB) is acquiring Independent Bank Group in a deal expected to close soon pending final conditions.

    Following is a summary of the change that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    Jan 3, 2025

    S&P SmallCap 600

    Addition

    Acadia Pharmaceuticals

    ACAD

    Health Care

    Jan 3, 2025

    S&P SmallCap 600

    Deletion

    Independent Bank Group

    IBTX

    Financials

    For more information about S&P Dow Jones Indices, please visit www.spdji.com 

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com. 

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected] 

    Media Inquiries

    [email protected] 

    Cision View original content:https://www.prnewswire.com/news-releases/acadia-pharmaceuticals-set-to-join-sp-smallcap-600-302340435.html

    SOURCE S&P Dow Jones Indices

    Get the next $ACAD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ACAD
    $IBTX
    $SPGI
    $SSB

    CompanyDatePrice TargetRatingAnalyst
    SouthState Corporation
    $SSB
    5/21/2025$110.00Buy
    Jefferies
    ACADIA Pharmaceuticals Inc.
    $ACAD
    5/21/2025$35.00Hold → Buy
    Deutsche Bank
    SouthState Corporation
    $SSB
    5/13/2025$106.00Buy
    Truist
    S&P Global Inc.
    $SPGI
    4/10/2025$600.00Buy
    BofA Securities
    SouthState Corporation
    $SSB
    4/2/2025$120.00 → $115.00Outperform → Strong Buy
    Raymond James
    SouthState Corporation
    $SSB
    4/1/2025$120.00Overweight
    Barclays
    S&P Global Inc.
    $SPGI
    3/12/2025$599.00Outperform
    Mizuho
    ACADIA Pharmaceuticals Inc.
    $ACAD
    2/11/2025$22.00Hold
    Deutsche Bank
    More analyst ratings

    $ACAD
    $IBTX
    $SPGI
    $SSB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

      Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-9) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 210793, Application Classification: Efficacy

      9/18/23 10:47:05 AM ET
      $ACAD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

      Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-12) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 207318, Application Classification: Efficacy

      9/18/23 10:40:05 AM ET
      $ACAD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • FDA Approval for DAYBUE issued to ACADIA PHARMS INC

      Submission status for ACADIA PHARMS INC's drug DAYBUE (ORIG-1) with active ingredient TROFINETIDE has changed to 'Approval' on 03/10/2023. Application Category: NDA, Application Number: 217026, Application Classification: Type 1 - New Molecular Entity

      3/13/23 10:37:07 AM ET
      $ACAD
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ACAD
    $IBTX
    $SPGI
    $SSB
    SEC Filings

    See more
    • SouthState Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - SouthState Corp (0000764038) (Filer)

      7/3/25 2:01:26 PM ET
      $SSB
      Major Banks
      Finance
    • SEC Form 11-K filed by S&P Global Inc.

      11-K - S&P Global Inc. (0000064040) (Filer)

      6/25/25 6:16:08 PM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • SEC Form 11-K filed by SouthState Corporation

      11-K - SouthState Corp (0000764038) (Filer)

      6/20/25 11:22:12 AM ET
      $SSB
      Major Banks
      Finance

    $ACAD
    $IBTX
    $SPGI
    $SSB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced that on July 2, 2025, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 35,607 shares of common stock and 29,571 restricted stock units ("RSUs") to seventeen new employees under Acadia's 2024 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4). Each stock option has an exercise price per share equal to $21.24 per share, Acadia's closing trading price on July 2, 2025, and will vest over four years, with 25% of

      7/3/25 4:05:00 PM ET
      $ACAD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SouthState Corporation to Announce Quarterly Earnings Results on Thursday, July 24, 2025

      WINTER HAVEN, Fla., July 3, 2025 /PRNewswire/ -- SouthState Corporation (NYSE:SSB) ("SouthState") announced today that it will release second quarter 2025 earnings results on Thursday, July 24, 2025, after the market closes. Upon release, investors may access a copy of SouthState's earnings results at the Company's website at www.SouthStateBank.com under Investor Relations, News, News & Market Data section. SouthState will host a conference call on Friday, July 25, 2025 at 9:00 a.m. (ET) to discuss its second quarter 2025 results. Investors may call in (toll free) by dialing (888) 350-3899 within the US and (646) 960-0343 for all other locations (host: Will Matthews, CFO). The conference ID

      7/3/25 2:00:00 PM ET
      $SSB
      Major Banks
      Finance
    • Datadog Set to Join S&P 500

      NEW YORK, July 2, 2025 /PRNewswire/ -- Datadog Inc. (NASD: DDOG) will replace Juniper Networks Inc. (NYSE:JNPR) in the S&P 500 effective prior to the opening of trading on Wednesday, July 9. S&P 500 constituent Hewlett Packard Enterprise Co. (NYSE:HPE) acquired Juniper Networks on July 2.  Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector July 9, 2025 S&P 500 Addition Datadog DDOG Information Technology July 9, 2025 S&P 500 Deletion Juniper Networks JNPR Information Technology For more information about S&P Dow Jones Indices, please visit www.spdji.com ABOUT S&

      7/2/25 5:55:00 PM ET
      $DDOG
      $HPE
      $JNPR
      $SPGI
      Computer Software: Prepackaged Software
      Technology
      Retail: Computer Software & Peripheral Equipment
      Computer Communications Equipment

    $ACAD
    $IBTX
    $SPGI
    $SSB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Froetscher Janet P bought $250,018 worth of shares (2,717 units at $92.02), increasing direct ownership by 138% to 4,689 units (SEC Form 4)

      4 - SouthState Corp (0000764038) (Issuer)

      3/11/25 4:10:14 PM ET
      $SSB
      Major Banks
      Finance
    • Director Smith G Stacy bought $290,160 worth of shares (3,100 units at $93.60), increasing direct ownership by 9% to 36,779 units (SEC Form 4)

      4 - SouthState Corp (0000764038) (Issuer)

      3/6/25 4:49:33 PM ET
      $SSB
      Major Banks
      Finance
    • Director Jacoby Rebecca bought $8,971 worth of shares (69 units at $130.01), increasing direct ownership by 17% to 469 units (SEC Form 4)

      4 - S&P Global Inc. (0000064040) (Issuer)

      6/17/24 4:04:40 PM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $ACAD
    $IBTX
    $SPGI
    $SSB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Jefferies initiated coverage on South State with a new price target

      Jefferies initiated coverage of South State with a rating of Buy and set a new price target of $110.00

      5/21/25 9:01:11 AM ET
      $SSB
      Major Banks
      Finance
    • ACADIA Pharmaceuticals upgraded by Deutsche Bank with a new price target

      Deutsche Bank upgraded ACADIA Pharmaceuticals from Hold to Buy and set a new price target of $35.00

      5/21/25 8:39:09 AM ET
      $ACAD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Truist initiated coverage on South State with a new price target

      Truist initiated coverage of South State with a rating of Buy and set a new price target of $106.00

      5/13/25 9:45:06 AM ET
      $SSB
      Major Banks
      Finance

    $ACAD
    $IBTX
    $SPGI
    $SSB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Brege Laura sold $314,634 worth of shares (14,446 units at $21.78), decreasing direct ownership by 49% to 15,095 units (SEC Form 4)

      4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)

      6/5/25 6:01:14 PM ET
      $ACAD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Daly James M converted options into 9,387 shares, increasing direct ownership by 38% to 34,041 units (SEC Form 4)

      4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)

      6/2/25 6:05:06 PM ET
      $ACAD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Ndu Adora converted options into 9,387 shares, increasing direct ownership by 61% to 24,801 units (SEC Form 4)

      4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)

      6/2/25 6:05:12 PM ET
      $ACAD
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ACAD
    $IBTX
    $SPGI
    $SSB
    Leadership Updates

    Live Leadership Updates

    See more
    • Datadog Set to Join S&P 500

      NEW YORK, July 2, 2025 /PRNewswire/ -- Datadog Inc. (NASD: DDOG) will replace Juniper Networks Inc. (NYSE:JNPR) in the S&P 500 effective prior to the opening of trading on Wednesday, July 9. S&P 500 constituent Hewlett Packard Enterprise Co. (NYSE:HPE) acquired Juniper Networks on July 2.  Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector July 9, 2025 S&P 500 Addition Datadog DDOG Information Technology July 9, 2025 S&P 500 Deletion Juniper Networks JNPR Information Technology For more information about S&P Dow Jones Indices, please visit www.spdji.com ABOUT S&

      7/2/25 5:55:00 PM ET
      $DDOG
      $HPE
      $JNPR
      $SPGI
      Computer Software: Prepackaged Software
      Technology
      Retail: Computer Software & Peripheral Equipment
      Computer Communications Equipment
    • Ralliant Set to Join S&P SmallCap 600

      NEW YORK, June 25, 2025 /PRNewswire/ -- Ralliant Corp. (NYSE:RAL) will replace Wolfspeed Corp. (NYSE:WOLF) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 1. S&P 500 constituent Fortive Corp. (NYSE:FTV) is spinning off Ralliant in a transaction expected to be completed on June 30. Fortive will remain in the S&P 500 post spin-off. Wolfspeed announced its intention to file for bankruptcy on or before July 1 and is therefore no longer eligible for continued inclusion in the S&P SmallCap 600. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker

      6/25/25 6:12:00 PM ET
      $FTV
      $SPGI
      $WOLF
      Industrial Machinery/Components
      Industrials
      Finance: Consumer Services
      Finance
    • APi Group Set to Join S&P MidCap 400

      NEW YORK, June 18, 2025 /PRNewswire/ -- APi Group Corp. (NYSE:APG) will replace United States Steel Corp. (NYSE:X) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, June 24. Nippon Steel Corp. (TSE: 5401) acquired United States Steel in a deal that closed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date  Index Name  Action  Company Name  Ticker  GICS Sector   June 24, 2025   S&P MidCap 400  Addition  APi Group   APG  Industrials   June 24, 2025   S&P MidCap 400  Deletion  United States Steel  X  Materials  For more information about S&P Dow Jones Indices, please visit www.spdji.com

      6/18/25 5:46:00 PM ET
      $APG
      $SPGI
      $X
      Engineering & Construction
      Consumer Discretionary
      Finance: Consumer Services
      Finance

    $ACAD
    $IBTX
    $SPGI
    $SSB
    Financials

    Live finance-specific insights

    See more
    • SouthState Corporation to Announce Quarterly Earnings Results on Thursday, July 24, 2025

      WINTER HAVEN, Fla., July 3, 2025 /PRNewswire/ -- SouthState Corporation (NYSE:SSB) ("SouthState") announced today that it will release second quarter 2025 earnings results on Thursday, July 24, 2025, after the market closes. Upon release, investors may access a copy of SouthState's earnings results at the Company's website at www.SouthStateBank.com under Investor Relations, News, News & Market Data section. SouthState will host a conference call on Friday, July 25, 2025 at 9:00 a.m. (ET) to discuss its second quarter 2025 results. Investors may call in (toll free) by dialing (888) 350-3899 within the US and (646) 960-0343 for all other locations (host: Will Matthews, CFO). The conference ID

      7/3/25 2:00:00 PM ET
      $SSB
      Major Banks
      Finance
    • S&P Global Schedules Second Quarter 2025 Earnings Announcement and Conference Call for Thursday, July 31, 2025

      NEW YORK, June 26, 2025 /PRNewswire/ -- S&P Global's (NYSE:SPGI) second quarter 2025 results will be issued on Thursday, July 31, 2025 via news release at approximately 7:15 a.m. Eastern Daylight Time. The news release will be available at www.spglobal.com. Martina Cheung, President and CEO; Eric Aboaf, Chief Financial Officer; and Mark Grant, Senior Vice President, Investor Relations and Treasurer, will host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on July 31, 2025 to discuss the Company's second quarter 2025 financial results. The presentation is open to all interested parties and may include forward-looking information. The presenters' slides, supplemental deck, a

      6/26/25 4:00:00 PM ET
      $SPGI
      Finance: Consumer Services
      Finance
    • S&P 500 Q1 2025 Buybacks Set Quarterly Record at $293 Billion, Up 20.6%, Helping EPS Growth; Impact and Expenditures Expected to Decline in Q2 2025

      S&P 500 Q1 2025 buybacks were $293.5 billion, setting a quarterly record, previously held by Q1 2022's $281.0 billion expenditure (when prices were 23.9% lower), and were up 20.6% from Q4 2024's $243.2 billion and up 23.9% from Q1 2024's $236.8 billionThe 12-month March 2025 expenditure was $999.2 billion and was up 22.4% from the 12-month March 2024 expenditure of $816.5 billion Communication Services increased spending by 56.5% and Information Technology increased 25.8%, as Consumer Staples and Consumer Discretionary reduced their spending by 25.6% and 16.8%, respectively The net buyback 1% tax reduced Q1 2025 operating earnings by 0.50% and As Reported GAAP by 0.53%, as the 12-month cost

      6/25/25 9:00:00 AM ET
      $SPGI
      Finance: Consumer Services
      Finance

    $ACAD
    $IBTX
    $SPGI
    $SSB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by SouthState Corporation

      SC 13G/A - SouthState Corp (0000764038) (Subject)

      11/14/24 1:28:29 PM ET
      $SSB
      Major Banks
      Finance
    • Amendment: SEC Form SC 13G/A filed by ACADIA Pharmaceuticals Inc.

      SC 13G/A - ACADIA PHARMACEUTICALS INC (0001070494) (Subject)

      11/14/24 6:48:52 AM ET
      $ACAD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G filed by SouthState Corporation

      SC 13G - SouthState Corp (0000764038) (Subject)

      2/14/24 10:04:34 AM ET
      $SSB
      Major Banks
      Finance